![](/imager/uploads/Companies/Kanvas-Bio/43029/Kanvas2_6439e647a38ed5b4d852739476ebaac9.webp)
![](/uploads/logos/_logo_h/Umoja-logo-black.png)
CAR‑T immunotherapy — in which a patient’s own T cells are removed from their body, reprogrammed in the lab to target and destroy cancer cells, and then reintroduced — has saved the lives of thousands of leukemia, lymphoma, and myeloma patients. But the procedure is slow, expensive, and hazardous. Umoja is developing a vector that delivers RNA instructions for the needed cancer-targeting receptors directly into the bloodstream, potentially lowering the risks and costs of cancer treatment and generating lasting remissions.
News & Insights
![](/imager/uploads/Companies/Kanvas-Bio/43029/Kanvas2_6439e647a38ed5b4d852739476ebaac9.webp)
Explore Companies
![](/imager/uploads/logos/59287/odyssey-logo_black_117378e58441a39758ec294c229f7090.webp)
Odyssey AI
Breakthrough generative AI for 3D visual assets
![](/imager/uploads/logos/59060/ElectronX-Black_117378e58441a39758ec294c229f7090.webp)
ElectronX
Building a CFTC-regulated electricity derivatives exchange
![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
![](/imager/uploads/logos/58727/valar-labs-logo-black_117378e58441a39758ec294c229f7090.webp)
Valar Labs
Using AI models trained on digital pathology images to help oncologists make smarter cancer treatment decisions